Soranib 200 Soranib 200 contains Sorafenib 200 mg, a targeted anti-cancer medicine used to treat advanced cancers by interfering with the signals that help cancer cells grow and spread. It also limits the development of new blood vessels that tumors need for nourishment, helping to slow disease progression. Soranib is commonly prescribed for patients with advanced liver cancer, kidney cancer, and certain types of thyroid cancer. The medicine is taken orally and should be used only under the guidance of an experienced oncologist.